Dehydrotrametenolic acid (Dehydroeburicoic acid) induces necrotic cell death that involves Ca(2+) overload, mitochondrial dysfunction, and calpain activation in human glioblastomas.

Polyporenic acid C shows inhibitory activity against human collagenase.

1. 3-Dehydrotrametenolic acid can be a potential anticancer agent against H-ras transformed tumor. 2. Dehydrotrametenolic acid is a promising candidate for a new type of insulin-sensitizing drug.

Poricoic acid A (Poricoic acid A(F)) is a natural product with antitumor activity. It also enhances melatonin inhibition of AKI-to-CKD transition by regulating the Gas6/AxlNFκB/Nrf2 axis.

Dehydrotumulosic acid shows anti-inflammatory activity.

Pachymic acid (3-O-Acetyltumulosic acid) is a natural product, and inhibits Akt and ERK signaling pathways.

3-O-Acetyl-16α-hydroxytrametenolic acid exhibits inhibitory activities against AAPH-induced hemolysis of red blood cells and demonstrates strong inhibitory effects on 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice.

Dehydroeburicoic acid monoacetate (3-O-Acetyldehydroeburicoic acid) is a triterpenoid of lanolin isolated from Wolfiporia cocos.

Poricoic acid B shows inhibitory activity against TPA-induced ear inflammatory oedema, it also shows potent inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA)

(S)-Leucic acid is an amino acid metabolite used as a muscle builder.